REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/10/2025
Back to search
Official data from USPTO
ORTHOCELL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ORTHOCELL
ST13
US500000079246526Class
5, 42, 44
Filing
79246526
Registration
6004489
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/10/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
10/24/2018
Registration date
03/10/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2020
Last transaction
03/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
O'BRIEN, JENNIFER
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Orthocell Limited
Representatives
Matthew J. Stark Price Heneveld LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Stem cells for medical purposes; collagen for medical use; biodegradable implants comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; implant materials comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration in surgery; implantable materials comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; implants comprising biological material being living cells and implantable scaffolds comprising biological materials for guided tissue regeneration; surgical implants comprised of living cells; therapeutic agentstherapeutic agents for tissue regeneration; therapeutic biological productsbiological cell cultures for medical purposesBiological tissue graftsBiological preparations for guided tissue regeneration; medical preparations for the treatment of tissue repair; guided tissue regeneration materialsimplants comprising biological materials being living cells and implantable scaffolds comprising biological materials; biological preparations for medical purposes for use in guided tissue regeneration for tissue repair; tissue-regenerative medical preparations for use in guided tissue regeneration of damaged tissue; biological materials for medical usesurgical implants comprised of living cellsBiological tissue graftsBiological materials for medical purposes being living cells and implantable scaffolds comprising biological materials; Collagen for medical purposescollagen based scaffolding for biomechanical support and stabilisation; Cells for medical or clinical usecellular therapeutic tendon and cartilage regeneration products
Class 42
Medical research; scientific and technological servicesproduct research and development relating to tissue regeneration products and techniques in the field of biomechanical and cellular therapeutic medical techniques; scientific research relating to biology; scientific and technological research and design services relating to biomechanical and cellular therapeutic medical techniques
Class 44
Advisory services relating to medical services; medical services; medical advisory services; medical care services; medical health assessment services; medical treatment services of regeneration of damaged tissue and for tissue repair; provision of medical information; provision of medical services; medical servicesincluding those relating to biomechanical and cellular therapeutic medical techniques
Publications
History of USPTO decisions and trademark events.
33 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/07/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/19/2020
FIMP
FINAL DISPOSITION PROCESSED
07/19/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/10/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/24/2019
PUBO
PUBLISHED FOR OPPOSITION
12/24/2019
GPNX
NOTIFICATION PROCESSED BY IB
12/20/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/04/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/04/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2019
ALIE
ASSIGNED TO LIE
11/15/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
10/29/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/29/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
10/29/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/29/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/23/2019
GNFR
FINAL REFUSAL E-MAILED
09/23/2019
CNFR
FINAL REFUSAL WRITTEN
09/23/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2019
RFNT
REFUSAL PROCESSED BY IB
03/02/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/12/2019
RFRR
REFUSAL PROCESSED BY MPU
02/12/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/06/2019
CNRT
NON-FINAL ACTION WRITTEN
02/05/2019
DOCK
ASSIGNED TO EXAMINER
01/31/2019
MAFR
APPLICATION FILING RECEIPT MAILED
12/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/30/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/29/2018
Continuous trademark protection
Get notified about every new filing that threatens ORTHOCELL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.